1.Vena cava thrombosis after vena cava filter placement:Incidence and risk factors
Yajuan GUO ; Jun FENG ; Tianrong QU ; Yan QU ; Yamin LIU ; Yushun ZHANG ; Hongyan TIAN ; Aiqun MA
Journal of Geriatric Cardiology 2011;08(2):99-103
Background The objective of this study was to assess the clinical safety and efficacy of vena cava filter (VCF) placement,with particular emphasis on the incidence and risk factors of inferior vena cava thrombosis (VCT) after VCF placement.Methods Clinical data of patients with venous thromboembolism (VTE),with or without placement of VCF,were analyzed in a retrospective single-center audit of medical records from January 2005 to June 2009.The collected data included demographics,procedural details,filter type,indications,and complications.Results A total of 168 cases of VTE (82 with VCF; 86 without VCF) were examined.Over a median follow-up of 24.2months,VCT occurred in 18 of 82 patients with VCFs (11 males,7 females,mean age 55.4 years).In 86 patients without VCFs,VCT occurred in only 6 individuals (4 males,2 females) during the study period.VCT was observed more frequently in patients fitted with VCFs than in those without VCFs (22% vs.7.0%).Conclusions The incidence of VCT in patients with VTE after VCF implantation was 22% approximately.Anticoagulation therapy should be continued for all patients with VCF placement,unless there is a specific contraindication.Almost all instances of VCT in patients with VCF implants in our study occurred after stopping anticoagulation treetment.The use of VCFs is increasing,and more trials are needed to confirm their benefit and accurately assess their safety.
2.6 ⁃gingerol relieves cell apoptosis , oxidative stress and neuroinflammation in rats with Alzheimer disease by activating Wnt/β⁃catenin signaling pathway
Jiao Li ; Youyuan Xiao ; Qin Xie ; Tianrong Ma ; Jianping Li ; Jun Duan ; Mao Su
Acta Universitatis Medicinalis Anhui 2022;57(1):95-100
Objective :
To investigate the effects of 6⁃gingerol on amyloid β ⁃protein(Aβ) induced apoptosis , oxidative stress and neuroinflammation in Alzheimer's disease(AD) rats by regulating Wnt/β⁃catenin signaling pathway.
Methods :
The rat model of AD was established by injecting Aβ into hippocampus of bilateral brain. The rats were
randomly divided into six groups : control group , model group , low⁃dose 6⁃gingerol group , medium⁃dose 6⁃gingerol group , high⁃dose 6 ⁃gingerol group and positive control group. Nerve injury was evaluated by nerve injury score , brain water content was measured by dry/wet method , and hippocampal histological injury was measured by HE staining. The apoptosis of hippocampal cells was detected by flow cytometry and TUNEL staining. The protein levels of iNOS , IL⁃6 , TNF⁃α , SOD , GSH⁃Px and MDA were detected by ELISA. The mRNA and protein relative expression levels of Wnt and β ⁃catenin were detected by qRT⁃PCR and Western blot.
Results :
Compared with the model group , after 6⁃gingerol treatment , nerve injury score decreased , brain water content decreased , the apoptosis rate decreased , the expression of iNOS , IL⁃6 and TNF⁃α decreased , SOD and GSH⁃Px protein content increased , while MDA protein content decreased. The mRNA and protein relative expression levels of Wnt and β ⁃catenin were up⁃regulated.
Conclusion
6 ⁃gingerol can reduce apoptosis , oxidative stress and neuroinflammation in AD rats by activating Wnt/β⁃catenin signaling pathway.